Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with stakeholders on access to the RSV vaccination for people over 80.
There is currently no advice on respiratory syncytial virus (RSV) vaccination for those aged over 80 years old to discuss with stakeholders. The Department accepted the advice of the Joint Committee on Vaccination and Immunisation (JCVI). The JCVI is not a stakeholder but the independent expert committee that advises the Government on matters to do with immunisation.
In June 2023, the JCVI advised an RSV immunisation programme for older adults aged 75 years old and above. The committee suggested an initial programme to potentially vaccinate a cohort aged from 75 to 80 years old, and then for those turning 75 years old in subsequent years, and this is the current policy for the programme. In the JCVI’s statement summarising the advice for the RSV programme, the committee stated that an extension to the initial programme would be considered when there is more certainty about protection in the very elderly and the real-world impact of the programme in 75 to 80 year olds.
In line with JCVI advice, RSV vaccination programmes to protect older adults and newborn babies, via maternal vaccination, began on 1 September 2024 in England. The Department will consider any further JCVI advice on who should be offered an RSV immunisation as the committee continues to keep the evidence under review.